Newcastle biotech pioneer Nanovery seals £1.1m funding boost
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Nanovery hails 'milestone' £1.1 million funding boost
A lifesciences company pioneering advanced disease detection and drug development has secured a £1.1 million funding boost to scale its innovative platform. Nanovery, which specialises in RNA therapeutics, has secured investment from Northstar Ventures and Smartlink. The backing includes £450,000 from the North East Innovation Fund, supported by the European Regional Development…
Axios hires Davis to cover biotech deals
Axios has hired Katherine Davis as its biotechnology deals reporter. Davis has been at Crain’s Chicago Business covering health care and life sciences companies. She previously was a general assignment and tech startup reporter at Crain’s Chicago. She previously reported for Cardiovascular Business and Chicago Inno and completed two internships at Crain’s sister publication Modern Healthcare. Davis […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
